These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 9502190

  • 21. The nitric oxide synthase inhibitor, Ng-nitro-L-arginine-methyl-ester, attenuates the delay in gastric emptying induced by hyperglycaemia in healthy humans.
    Kuo P, Gentilcore D, Nair N, Stevens JE, Wishart JM, Lange K, Gilja OH, Hausken T, Horowitz M, Jones KL, Rayner CK.
    Neurogastroenterol Motil; 2009 Nov; 21(11):1175-e103. PubMed ID: 19460102
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Gastric emptying and release of incretin hormones after glucose ingestion in humans.
    Schirra J, Katschinski M, Weidmann C, Schäfer T, Wank U, Arnold R, Göke B.
    J Clin Invest; 1996 Jan 01; 97(1):92-103. PubMed ID: 8550855
    [Abstract] [Full Text] [Related]

  • 24. Effects of taurocholic acid on glycemic, glucagon-like peptide-1, and insulin responses to small intestinal glucose infusion in healthy humans.
    Wu T, Bound MJ, Standfield SD, Jones KL, Horowitz M, Rayner CK.
    J Clin Endocrinol Metab; 2013 Apr 01; 98(4):E718-22. PubMed ID: 23418316
    [Abstract] [Full Text] [Related]

  • 25. Effect of hyperglycaemia on gallbladder motility in type 1 (insulin-dependent) diabetes mellitus.
    de Boer SY, Masclee AA, Lam WF, Lemkes HH, Schipper J, Fröhlich M, Jansen JB, Lamers CB.
    Diabetologia; 1994 Jan 01; 37(1):75-81. PubMed ID: 8150234
    [Abstract] [Full Text] [Related]

  • 26. Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.
    Meier JJ, Kemmeries G, Holst JJ, Nauck MA.
    Diabetes; 2005 Jul 01; 54(7):2212-8. PubMed ID: 15983224
    [Abstract] [Full Text] [Related]

  • 27. Glucagon effects on the human small intestine.
    Patel GK, Whalen GE, Soergel KH, Wu WC, Meade RC.
    Dig Dis Sci; 1979 Jul 01; 24(7):501-8. PubMed ID: 456237
    [Abstract] [Full Text] [Related]

  • 28. Hyperinsulinaemia impairs gastrointestinal motility and slows carbohydrate absorption.
    Eliasson B, Björnsson E, Urbanavicius V, Andersson H, Fowelin J, Attvall S, Abrahamsson H, Smith U.
    Diabetologia; 1995 Jan 01; 38(1):79-85. PubMed ID: 7744232
    [Abstract] [Full Text] [Related]

  • 29. No effects of acute hyperglycaemia and hyperinsulinaemia on skin microcirculation and endothelial markers in Type II diabetes mellitus.
    Oomen PH, Kant GD, Dullaart RP, Tervaert JW, Reitsma WD, Smit AJ.
    Scand J Clin Lab Invest; 2004 Apr 01; 64(2):119-27. PubMed ID: 15115249
    [Abstract] [Full Text] [Related]

  • 30. Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections.
    Nauck MA, Siemsglüss J, Orskov C, Holst JJ.
    Z Gastroenterol; 1996 Mar 01; 34(3):159-66. PubMed ID: 8650968
    [Abstract] [Full Text] [Related]

  • 31. A novel hyperglycaemic clamp for characterization of islet function in humans: assessment of three different secretagogues, maximal insulin response and reproducibility.
    Fritsche A, Stefan N, Hardt E, Schützenauer S, Häring H, Stumvoll M.
    Eur J Clin Invest; 2000 May 01; 30(5):411-8. PubMed ID: 10809901
    [Abstract] [Full Text] [Related]

  • 32. The plasma C-peptide and insulin responses to stimulation with intravenous glucagon and a mixed meal in well-controlled type 2 (non-insulin-dependent) diabetes mellitus: dependency on acutely established hyperglycaemia.
    Gjessing HJ, Reinholdt B, Pedersen O.
    Diabetologia; 1989 Dec 01; 32(12):858-63. PubMed ID: 2693165
    [Abstract] [Full Text] [Related]

  • 33. Effects of insulin and glucose on urea synthesis in normal man, independent of pancreatic hormone secretion.
    Hamberg O, Vilstrup H.
    J Hepatol; 1994 Sep 01; 21(3):381-7. PubMed ID: 7836708
    [Abstract] [Full Text] [Related]

  • 34. Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.
    Creutzfeldt WO, Kleine N, Willms B, Orskov C, Holst JJ, Nauck MA.
    Diabetes Care; 1996 Jun 01; 19(6):580-6. PubMed ID: 8725855
    [Abstract] [Full Text] [Related]

  • 35. Hyperglycemia acutely lowers the postprandial excursions of glucagon-like Peptide-1 and gastric inhibitory polypeptide in humans.
    Vollmer K, Gardiwal H, Menge BA, Goetze O, Deacon CF, Schmidt WE, Holst JJ, Meier JJ.
    J Clin Endocrinol Metab; 2009 Apr 01; 94(4):1379-85. PubMed ID: 19174495
    [Abstract] [Full Text] [Related]

  • 36. The effect of gastric inhibitory polypeptide on intestinal glucose absorption and intestinal motility in mice.
    Ogawa E, Hosokawa M, Harada N, Yamane S, Hamasaki A, Toyoda K, Fujimoto S, Fujita Y, Fukuda K, Tsukiyama K, Yamada Y, Seino Y, Inagaki N.
    Biochem Biophys Res Commun; 2011 Jan 07; 404(1):115-20. PubMed ID: 21095180
    [Abstract] [Full Text] [Related]

  • 37. Interaction of insulin, glucagon-like peptide 1, gastric inhibitory polypeptide, and appetite in response to intraduodenal carbohydrate.
    Lavin JH, Wittert GA, Andrews J, Yeap B, Wishart JM, Morris HA, Morley JE, Horowitz M, Read NW.
    Am J Clin Nutr; 1998 Sep 07; 68(3):591-8. PubMed ID: 9734735
    [Abstract] [Full Text] [Related]

  • 38. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS, Draeger KE, van Iperen AM, Martini C, Aarsen M, Heine RJ.
    Diabet Med; 1997 Jul 07; 14(7):556-63. PubMed ID: 9223393
    [Abstract] [Full Text] [Related]

  • 39. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
    Vilsbøll T, Knop FK, Krarup T, Johansen A, Madsbad S, Larsen S, Hansen T, Pedersen O, Holst JJ.
    J Clin Endocrinol Metab; 2003 Oct 07; 88(10):4897-903. PubMed ID: 14557471
    [Abstract] [Full Text] [Related]

  • 40. Effects of hyperglycemia on interdigestive gastrointestinal motility in humans.
    Björnsson ES, Urbanavicius V, Eliasson B, Attvall S, Smith U, Abrahamsson H.
    Scand J Gastroenterol; 1994 Dec 07; 29(12):1096-104. PubMed ID: 7886397
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.